Newsbenzinga
Moleculin Biotech Announces Mexican Patent For Lung-Targeted Annamycin Formulation, In Force Until November 23, 2040
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…